AbbVie Wants Mass. Biotech Firm To Pay Up For Drug Work
By Julie Manganis · August 1, 2024, 4:56 PM EDT
AbbVie Inc. says it's still owed nearly $1 million by a Massachusetts biopharmaceutical company for materials and work it provided as the smaller firm prepared to seek U.S. Food and Drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login